• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Ki67 表达作为口腔黏膜下纤维性变潜在生物标志物的研究:免疫组织化学研究。

Expression of Ki67 as potential biomarker in oral submucous fibrosis: An immunohistochemical study.

机构信息

Department of Oral Medicine and Radiology, School of Dental Sciences, Krishna Institute of Medical Sciences (KIMSDU), Karad, Satara, Maharashtra, India.

Department of Pathology, School of Dental Sciences, Krishna Institute of Medical Sciences (KIMSDU), Karad, Satara, Maharashtra, India.

出版信息

Indian J Dent Res. 2022 Jul-Sep;33(3):272-276. doi: 10.4103/ijdr.ijdr_551_21.

DOI:10.4103/ijdr.ijdr_551_21
PMID:36656187
Abstract

BACKGROUND

Oral submucous fibrosis (OSMF) is a potentially malignant disorder (PMD) known to transform into oral cancer. One of the important hallmarks of malignant transformation is the uncontrolled growth rate, commonly reflected as increased cell proliferation which can be significantly detected by proliferative markers such as a high Ki-67 index.

AIM

The aim of this study is to evaluate the degree and pattern of expression of Ki67 in OSMF, oral squamous cell carcinoma (OSCC) and in normal mucosal (NOM) patients and to correlate the Ki67 expression with clinical and histological grading of OSMF and OSCC patient.

MATERIALS AND METHODS

A prospective cross-sectional study was conducted over a duration of two years. An immunohistochemical study was performed for Ki76 expression on 35 cases of OSMF, 10 cases of OSCC and 10 normal mucosal patients.

STATISTICAL ANALYSIS

Data were analysed using SPSS version 21. Chi-squared test was used to analyse the differences between the intensity levels in OSMF, OSCC and NOM.

RESULTS

Expression of Ki67 was significantly higher in OSMF than that of NOM samples but less than that of OSCC samples. Expression of Ki67 increased with increasing grade of clinical and histological stages.

CONCLUSION

The study demonstrated a high incidence of Ki67 overexpression in OSMF and OSCC and showed a correlation between clinical and histological grading of OSMF and OSCC. Identification of high-risk oral PMDs and intervention at premalignant stages could constitute one of the key steps in reducing the mortality, morbidity and cost of treatment associated with malignant transformation of these diseases.

摘要

背景

口腔黏膜下纤维性变(OSMF)是一种已知可转化为口腔癌的潜在恶性疾病(PMD)。恶性转化的一个重要标志是不受控制的生长速度,通常表现为细胞增殖增加,这可以通过增殖标志物如高 Ki-67 指数显著检测到。

目的

本研究旨在评估 Ki67 在 OSMF、口腔鳞状细胞癌(OSCC)和正常黏膜(NOM)患者中的表达程度和模式,并将 Ki67 表达与 OSMF 和 OSCC 患者的临床和组织学分级相关联。

材料和方法

进行了为期两年的前瞻性横断面研究。对 35 例 OSMF、10 例 OSCC 和 10 例正常黏膜患者进行了 Ki76 表达的免疫组织化学研究。

统计学分析

使用 SPSS 版本 21 分析数据。卡方检验用于分析 OSMF、OSCC 和 NOM 之间的强度水平差异。

结果

Ki67 在 OSMF 中的表达明显高于 NOM 样本,但低于 OSCC 样本。Ki67 的表达随着临床和组织学阶段的增加而增加。

结论

该研究表明 OSMF 和 OSCC 中 Ki67 过度表达的发生率较高,并显示 OSMF 和 OSCC 的临床和组织学分级之间存在相关性。识别高危口腔 PMD 并在癌前阶段进行干预可能是降低这些疾病恶性转化相关死亡率、发病率和治疗成本的关键步骤之一。

相似文献

1
Expression of Ki67 as potential biomarker in oral submucous fibrosis: An immunohistochemical study.Ki67 表达作为口腔黏膜下纤维性变潜在生物标志物的研究:免疫组织化学研究。
Indian J Dent Res. 2022 Jul-Sep;33(3):272-276. doi: 10.4103/ijdr.ijdr_551_21.
2
Expression of Ki67 Biomarker in Oral Submucous Fibrosis with Clinico-Pathological Correlations: A Prospective Study.Ki67 生物标志物在口腔黏膜下纤维性变中的表达及其与临床病理相关性的前瞻性研究。
Asian Pac J Cancer Prev. 2022 Jan 1;23(1):253-259. doi: 10.31557/APJCP.2022.23.1.253.
3
Expression of hTERT in Oral Submucous Fibrosis and Oral Squamous Cell Carcinoma - an Immunohistochemical Analysis.端粒酶逆转录酶在口腔黏膜下纤维性变和口腔鳞状细胞癌中的表达——免疫组织化学分析。
Pathol Oncol Res. 2020 Jul;26(3):1573-1582. doi: 10.1007/s12253-019-00700-6. Epub 2019 Sep 5.
4
Molecular profiling of oral squamous cell carcinoma associated with oral submucous fibrosis.口腔黏膜下纤维性变相关口腔鳞状细胞癌的分子谱分析。
J Cancer Res Ther. 2022 Jan-Mar;18(1):55-65. doi: 10.4103/jcrt.JCRT_508_20.
5
Evaluation of PTEN immunoexpression in oral submucous fibrosis: role in pathogenesis and malignant transformation.口腔黏膜下纤维化中PTEN免疫表达的评估:在发病机制和恶性转化中的作用
Head Neck Pathol. 2012 Sep;6(3):314-21. doi: 10.1007/s12105-012-0341-z. Epub 2012 Mar 6.
6
Clinicopathological characteristics of oral squamous cell carcinoma arising from oral submucous fibrosis: A systematic review.口腔黏膜下纤维化继发口腔鳞状细胞癌的临床病理特征:一项系统评价
J Cancer Res Ther. 2023 Apr-Jun;19(3):537-542. doi: 10.4103/jcrt.jcrt_1467_21.
7
Comparison of Immunohistochemical Markers in Oral Submucous Fibrosis and Oral Submucous Fibrosis Transformed to Oral Squamous Cell Carcinoma-A Systematic Review and Meta-Analysis.口腔黏膜下纤维性变和口腔黏膜下纤维性变转化为口腔鳞状细胞癌的免疫组织化学标志物比较:系统评价和荟萃分析。
Int J Mol Sci. 2023 Jul 21;24(14):11771. doi: 10.3390/ijms241411771.
8
Expression of p53 as Potential Biomarker in Oral Submucous Fibrosis: An Immunohistochemical Study.p53表达作为口腔黏膜下纤维化潜在生物标志物的免疫组织化学研究
J Microsc Ultrastruct. 2023 Jan 5;11(2):75-80. doi: 10.4103/jmau.jmau_23_21. eCollection 2023 Apr-Jun.
9
Oral squamous cell carcinoma in the background of oral submucous fibrosis is a distinct clinicopathological entity with better prognosis.口腔黏膜下纤维性变背景下的口腔鳞状细胞癌是一种具有独特临床病理特征的疾病,其预后较好。
J Oral Pathol Med. 2017 Jul;46(6):448-453. doi: 10.1111/jop.12553. Epub 2017 Feb 28.
10
Significance of HIF-1α and CD105 in establishing oral squamous cell carcinoma associated with oral submucous fibrosis a distinct clinicopathological entity.HIF-1α 和 CD105 在确定与口腔黏膜下纤维性变相关的口腔鳞状细胞癌这一独特临床病理实体中的意义。
J Cancer Res Ther. 2022 Jan-Mar;18(1):33-41. doi: 10.4103/jcrt.JCRT_591_20.

引用本文的文献

1
Exploring Possible Diagnostic Precancerous Biomarkers for Oral Submucous Fibrosis: A Narrative Review.探索口腔黏膜下纤维化可能的癌前诊断生物标志物:一项叙述性综述。
Cancers (Basel). 2023 Sep 30;15(19):4812. doi: 10.3390/cancers15194812.